Story perspectives

Lawmakers Push for Medicare Coverage of Alzheimer’s Blood Tests

3/27/2026

Summary

Story summary

Representatives Paul Tonko (D-N.Y.) and Vern Buchanan (R-Fla.) urged support for the Alzheimer’s Screening and Prevention Act, which would allow Medicare to cover FDA-approved blood tests for early Alzheimer’s detection.
They argued that addressing Alzheimer’s proactively is essential and financially necessary as more than 7 million Americans are affected.
The Alzheimer’s Association notes that early detection enhances the effectiveness of new medications and helps individuals plan for their future.

1 of 1

Story summary

Representatives Paul Tonko (D-N.Y.) and Vern Buchanan (R-Fla.) urged support for the Alzheimer’s Screening and Prevention Act, which would allow Medicare to cover FDA-approved blood tests for early Alzheimer’s detection.
They argued that addressing Alzheimer’s proactively is essential and financially necessary as more than 7 million Americans are affected.
The Alzheimer’s Association notes that early detection enhances the effectiveness of new medications and helps individuals plan for their future.